Amy E. Weaver - 19 May 2021 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

SEC evidence 4 source fields
Form type
4
Accepted by SEC
20 May 2021, 17:24:37 UTC
Next filing
02 Jun 2021
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Anisha Mehta, Attorney-in-Fact for Amy Weaver

Key filing fact

Amy E. Weaver filed Form 4 for SALESFORCE.COM, INC. (CRM) on 20 May 2021.

Key facts

  • This page summarizes Amy E. Weaver's Form 4 filing for SALESFORCE.COM, INC. (CRM).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 May 2021, 17:24.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$514,813.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRM transaction

Common Stock

Options Exercise

Transaction value
$1,421,200
Shares
+8,800
Change %
+29%
Price
$161.50
Shares after
39,404
Date
19 May 2021
Ownership
Direct
Footnotes
F1
CRM transaction

Common Stock

Sale

Transaction value
$1,936,013
Shares
-8,800
Change %
-22%
Price
$220.00
Shares after
30,604
Date
19 May 2021
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-8,800
Change %
-7.2%
Price
$0.000000
Shares after
113,020
Date
19 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,800
Exercise price
$161.50
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Footnote F2

Weighted average price. These shares were sold in multiple transactions at prices ranging from $220.0000 to $220.0100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F3

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .